Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antigenics To Stimulate Immunology Projects With Stimulon From Aquila

Executive Summary

Antigenics expects to boost its infectious disease and autoimmune product development with Aquila's vaccine adjuvant Stimulon QS-21 following a proposed merger.

You may also be interested in...



Agenus Teams Up With NewVac On Russian Deal

The Massachusetts biotech has found a partner to commercialize its cancer vaccine in Russia and develop the drug for other indications.

Roche Kytril Acquisition From SmithKline Strengthens Hospital Focus In U.S.

Roche's acquisition of the anti-emetic Kytril from SmithKline Beecham will build on Roche's strength in the U.S. hospital market.

Roche Kytril Acquisition From SmithKline Strengthens Hospital Focus In U.S.

Roche's acquisition of the anti-emetic Kytril from SmithKline Beecham will build on Roche's strength in the U.S. hospital market.

Related Content

UsernamePublicRestriction

Register

PS036536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel